|Presenters:||Antony Haynes BA (Hons), Dip ION, BANT, CNHC|
|Topic:||A Functional Medicine Approach to Auto-Immune Conditions|
|Date and Time:||Wednesday 20th November 2013. Registration at 6pm. Seminar begins at 6.30pm, 9.30pm finish|
|Price:||£35 + VAT|
|Location:||Royal Society of Medicine
1 Wimpole Street
London, W1G 0AE
|CPD Approval||3 Hours from BANT and NNA|
Antony Haynes will provide a functional medicine perspective on a variety of auto-immune conditions and will present the information in a series of case histories from his clinical practice.
Antony will provide an update on the case histories he presented last year, with the intention of identifying what may be required for sustained improvements and positive outcomes.
This includes case histories of patients with rheumatoid arthritis, multiple sclerosis, scleroderma & Hashimoto’s hypothyroidism.
You will learn about the key principles of a number of auto-immune conditions, and what may well be required once the causes have been successfully addressed.
Antony will show you the specific test results which reveal key imbalances about these patients.
You will learn what specific nutritional therapy intervention may correct these specific imbalances, and help return the body to a state of improved function. Importantly, and emphasised in this follow on seminar are the metabolic issues that can occur after the condition’s primary cause has been dealt with. These metabolic imbalances almost always appear to disrupt a balanced biotransformation (detoxification) process leading to symptoms which can be similar to the auto-immune condition itself.
In addition to presenting the therapeutic nutritional intervention which targets the cause of the conditions, the gut lining integrity & immune system imbalances that are distinct characteristics of auto-immunity, Antony discusses the possible causes of these biotransformation disruptions, and presents the nutritional support that is required to resolve them. It is this last aspect that has led to sustained positive outcomes in a significant proportion of patients who had auto-immune conditions.